Octocells is a French biotechnology company based in Rouen that develops advanced three-dimensional (3D) cell culture solutions for bioproduction and research. Their core offering, the CellSpace HA platform, utilizes a patented, animal-free hyaluronic acid-based bioscaffold. This technology is designed to address limitations in traditional 2D culture and animal-derived matrices by providing a highly scalable, standardized, and reproducible environment for cell growth. The system supports a variety of applications, including oncology, cell therapies, vaccine production, regenerative medicine, and cultivated proteins. By combining expertise in biomaterials with digital technologies such as the potential use of digital twins for bioreactor simulation the company aims to optimize production processes, reduce costs, and improve overall bioproduction efficiency.
Advanced Biomanufacturing and Ecosystem Enablers
Scale-up and manufacturing of complex therapiesMicro-factories for decentralised biomanufacturingSustainable and green biomanufacturingTechnological integration and cross-sectoral transfer
OctoCells offers a new cell-bioproduction platform: a body-like, 100% animal-free, customisable 3D scaffold + AI digital twin. Works for any cell type. Validated: ≥12× yield, −80% cost, −83% nutrients, +54% EV yield, 5-month culture.